Font Size: a A A

The Calcium-sensing Receptor And Hepatocyte Growth Factor Against Myocardial Cell Apoptosis Related Research

Posted on:2012-10-06Degree:MasterType:Thesis
Country:ChinaCandidate:L YanFull Text:PDF
GTID:2204330335481691Subject:Internal Medicine
Abstract/Summary:PDF Full Text Request
Objective To examine whether anti-apoptotic role of HGF in preventing cardiomyocytes injury induced by ischemia/reperfusion is associated with downregulation of calcium sensing receptor (CaSR) mRNA expression and Phosphoinositide-3 Kinase(PI3K) phosphorylation signaling pathway.Methods Neonatal rat cardiomyocytes were isolated and randomly divided into 7 groups: control group; ischemia/reperfusion group (I/R group); GdCl3 group; GdCl3+ NiCl2+ CdCl2 group; GdCl3+LY294002 group; GdCl3+ HGF group; GdCl3+ HGF+ LY294002 group. We incubated primary neonatal rat ventricular cardiomyocytes in ischemia-mimetic solution for 2h, then reincubated them in normal culture medium for 24h to establish a model of simulated ischemia/reperfusion(I/R). Cardiomyocyte apoptosis was detected by TUNEL. The expression of CaSR mRNA was detected by reverse transcriptase polymerase chain reaction(RT-PCR). In addition, we analyzed the expression of Caspase-3, Bcl-2 and Phosphoinositide-3 Kinase(PI3K) by Western blotting.Results The simulated I/R enhanced the expression of CaSR mRNA [I/R: (2.62±0.41); control: (1.00±0.31), P<0.01] and cardiomyocyte apoptosis[I/R: (15.32±2.54)%; control: (2.90±1.45)%, P<0.01]. GdCl3, further increased the expression of CaSR mRNA[GdCl3: (4.46±0.62); I/R: (2.62±0.41), P<0.01] and Cardiomyocyte apoptosis[GdCl3: (25.36±2.60)%; I/R: (15.32±2.54)%, P<0.01], along with upregulation of Caspase-3[GdCl3: (1.93±0.28); I/R: (1.50±0.21), P<0.01], downregulation of Bcl-2[GdCl3: (0.82±0.18); I/R: (1.71±0.30), P<0.01] and inhibiting PI3K phosphorylation[I/R: (0.87±0.08); GdCl3: (0.61±0.07); P<0.01]. Combination of GdCl3 with LY294002 increased Cardiomyocytes apoptosis[GdCl3+LY294002: (32.6±3.42)%; GdCl3: (25.36±2.60)%, P<0.01] but did not increased CaSR mRNA expression[GdCl3+ LY294002: (4.27±0.56); GdCl3: (4.46±0.62), P﹥0.05].Treatment of HGF decreased I/R- and GdCl3-induced apoptosis[GdCl3+HGF: (11.8±1.89)%; GdCl3: (25.36±2.60)%, P<0.05] by suppressing Caspase-3[GdCl3+ HGF: (1.12±0.23); GdCl3:(1.93±0.28), P<0.05;GdCl3+ HGF+LY294002: (1.87±0.31); GdCl3 + LY294002: (3.86±0.47), P<0.05] and promoting Bcl-2[GdCl3+ HGF: (2.56±0.54); GdCl3: (0.82±0.18), P<0.05;GdCl3+ HGF+LY294002: (1.68±0.28); GdCl3 + LY294002: (0.68±0.13), P<0.05] and PI3K phosphoration expression[GdCl3+ HGF: (2.87±0.21); GdCl3: (0.61±0.07), P<0.05; GdCl3+ HGF+LY294002: (2.01±0.14); GdCl3 + LY294002: (0.44±0.10), P<0.05] in accordance with downregulation of CaSR mRNA expression[GdCl3+ HGF: (1.46±0.37); GdCl3: (4.46±0.62), P<0.01].Conclusion HGF exerts protective role in I/R-induced apoptosis at least in part by inhibiting CaSR mRNA expression along with promoting Bcl-2, suppressing Caspase-3 expression and stimulating PI3K phosphorylation signaling pathway.
Keywords/Search Tags:Myocardial ischemia/reperfusion injury, Hapatocyte growth factor, Receptors,Calcium-sensing, Apoptosis
PDF Full Text Request
Related items